维普期刊资源整合服务平台（V6.5）

41篇 您的检索式：作者名="Labarthe D"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Medium-chain fatty acids as metabolic therapy in cardiac disease显示文摘	LABARTHE F GELINAS R ROSIERS C D	2008	Cardiovascular Drugs and Therapy2008，22，2：	1
2	Immunotherapeutic potential of whole tumour cells显示文摘	Ward S Casey D Labarthe MC	2002	Cancer Immunol Immunother2002，51，7：	1
3	Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through2020 and beyond 显示文摘	Lloyd -Jones DM Hong Y Labarthe D	2010	Circulation2010，121，4：	1
4	Defining and setting national goals for cardiovascular health promotion and disease reduction:the American Heart Association's strategic Impact Goal through 2020 and beyond显示文摘	Lloyd-Jones DM Hong Y Labarthe D	2010	Circulation2010，121，：	1
5	Defining and setting national goals for cardiovascular health promotion and health promo- tion and disease reduction:the American Heart Association's strate- gic impact goal through 2020 and beyond 显示文摘	Lloyd-Jones DM Hong Y Labarthe D	2010	Circulation2010，121，4：	1
6	Sensitive determination of ephedrine and norephedrine in human plasma samples using derivatization with 9-fluorenylmethyl chloroformate and liquid chromatography显示文摘	Aymard G Labarthe B Warot D	2000	J Chromatogr B2000，744，1：	1
7	Immunotherapeutic potential of whole tumour cells 显示文摘	Ward S Casey D Labarthe M C	2002	Cancer Immunol Immunother2002，51，7：	1
8	American Heart Association Strategic Planning Task Force and Statistics Committee Defining and Setting National Goals for Cardiovascular Health Promotion and Dis- ease Reduction: the American Heart Association 's Strategic Impact Goal Through 2020 and Beyond 显示文摘	Lloyd-Jones DM Hang Y Labarthe D	2010	Circulation2010，121，4：	1
9	Defining andseting national goals for cardiovascular health promotionand disease reduction : The American heart association ’ sstrategic impact goal through 2020 and beyond显示文摘	Ooyd-Jones DM Hong Y Labarthe D	2010	Circu-lation2010，121，4：	1
10	Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond 显示文摘	Lloyd-Jones DM Hong Y Labarthe D	2010	Circulation2010，121，4：	1
11	代盐对临床预后的影响:一项系统综述和荟萃分析显示文摘代盐与脑卒中研究(salt substitute and stroke study, SSaSS)最近报道了富含钾的代盐通过降低血压对心血管结局和死亡的益处。本研究纳入更广泛的研究评估代盐的影响,并量化研究结果的一致性。方法:研究者检索截至2021年8月31日的PubMed、Embase和Cochrane图书馆的资料,纳入报告代盐对血压或临床预后影响的平行组、阶梯楔形或整群随机对照试验。	Yin X Rodgers A Perkovic A Huang L Li KC Yu J Wu Y Wu JHY Marklund M Huffman MD Miranda JJ Di Tanna GL Labarthe D Elliott P Tian M Neal B 刘青(译) 郑武洪(审校)	2022	中华高血压杂志2022，30，12：	1
12	Defining and setting national goals tor cardiovascular health promotion and disease reduc- tion: the American Heart Association's strategic impact goal through 2020 and beyond显示文摘	Lloyd-Jones DM Hang Y Labarthe D	2010	Circulation2010，121，4：	1
13	Defining and setting National goals for cardiovascular health promotion and disease reduction:the American Heart Association’s strategic Impact Goal through 2020 and beyond显示文摘	Lloyd-Jones DM HONG YL Labarthe D	2010	Circulation2010，121，4：	1
14	Defining and setting national goals for cardiovascular health promotion and disease reduction: the American heart association' s strategic impact goal through 2020 and beyond 显示文摘	Lloyd-Jones DM Hong YL Labarthe D	2010	Circulation2010，121，：	1
15	Defining and settingnational goals for cardiovascular health promotion and health promo- tion and disease reduction: the American Heart Association's strategic impact goal through 2020 and beyond 显示文摘	Lloyd-Jones DM Hong Y Labarthe D	2010	Circulation2010，121，4：	1
16	A cohort study of amyotrophic lateral sclerosis and parkinsonism-dementia on Guam and Rota显示文摘	Reed D Labarthe D Chert KM	1987	Am J Epidemiol1987，125，：	1
17	Defining and setting national goals for cardiovascular health promotion and health promo- tion and disease reduction : the American Heart Association ' s strate- gic impact goal through 2020 and beyond 显示文摘	Lloyd-Jones D M Hong Y Labarthe D	2010	Circulation2010，121，4：	1
18	Defining and setting national goals for cardiovascular health promotion and disease reduction, the American Heart Assiociation' s strategic impact goal through 2020 and beyond显示文摘	Lloyd-Jones DM Hong Y Labarthe D	2010	Circulation2010，121，4：	1
19	Immuno-therapeutic potential of whole tumour cells 显示文摘	Ward S Cascy D Labarthe MC	2002	Cancer Immunology Immunotherapy2002，51，：	1
20	Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond 显示文摘	Lloyd-Jones DM Hong Y Labarthe D	2010	Circulation2010，121，4：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示